Cargando…

CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect

Detalles Bibliográficos
Autores principales:	Liu, Mingyue, Wang, Xu, Du, Xuexiang, Zhang, Yan, Ai, Chunxia, Hu-Lieskovan, Siwen, Li, Tianhong, Devenport, Martin, Liu, Yang, Zheng, Pan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283527/ https://www.ncbi.nlm.nih.gov/pubmed/35835736 http://dx.doi.org/10.1038/s41392-022-01030-x

Ejemplares similares

CD24-Fc suppression of immune related adverse events in a therapeutic cancer vaccine model of murine neuroblastoma
por: Wu, Xiaofang, et al.
Publicado: (2023)

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice
por: Du, Xuexiang, et al.
Publicado: (2018)

Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy
por: Zhang, Yan, et al.
Publicado: (2019)

CD24Fc protects against viral pneumonia in simian immunodeficiency virus-infected Chinese rhesus monkeys
por: Tian, Ren-Rong, et al.
Publicado: (2020)

CD24Fc: an emerging COVID-19 therapy
por: Eckhardt, Christina M, et al.
Publicado: (2022)

CD24(+) Cell Depletion Permits Effective Enrichment of Thymic iNKT Cells While Preserving Their Subset Composition
por: Park, Joo-Young, et al.
Publicado: (2019)

Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues
por: Bailey, Christopher M., et al.
Publicado: (2022)

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
por: Welker, James, et al.
Publicado: (2022)

What does PD-L1 positive or negative mean?
por: Ribas, Antoni, et al.
Publicado: (2016)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
por: Dinnon III, Kenneth H., et al.
Publicado: (2019)

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
por: Muthana, Musleh M., et al.
Publicado: (2023)

Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey
por: Oshima, Tsutomu, et al.
Publicado: (2018)

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
por: Haderski, Gary J., et al.
Publicado: (2020)

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins
por: Wei, Wei-Qi, et al.
Publicado: (2014)

Insurance Does Not Affect Adverse Events While Awaiting Surgery for Ankle Trauma in One System
por: Dobbins, Adam B., et al.
Publicado: (2020)

Modulation of Allogeneic CD8(+) T-Cell Response by DZNep Controls GVHD While Preserving Hematopoietic Chimerism
por: Wang, Jina, et al.
Publicado: (2013)

CD24 enrichment protects while its loss increases susceptibility of juvenile chondrocytes towards inflammation
por: Lee, Jieun, et al.
Publicado: (2016)

Exosomes as a predictor tool of acquired resistance to melanoma treatment
por: Goedert, Lucas, et al.
Publicado: (2014)

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023)

Management of endophthalmitis while preserving the uninvolved crystalline lens
por: Townsend, Justin, et al.
Publicado: (2012)

Preserving Derivative Information while Transforming Neuronal Curves
por: Athey, Thomas L., et al.
Publicado: (2023)

Preserving Derivative Information while Transforming Neuronal Curves
por: Athey, Thomas L., et al.
Publicado: (2023)

Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
por: Kasprick, Anika, et al.
Publicado: (2020)

Mitotic Internalization of Planar Cell Polarity Proteins Preserves Tissue Polarity
por: Devenport, Danelle, et al.
Publicado: (2011)

Local Administration of Soluble CD40:Fc to the Salivary Glands of Non-Obese Diabetic Mice Does Not Ameliorate Autoimmune Inflammation
por: Roescher, Nienke, et al.
Publicado: (2012)

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019)

The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions
por: Osorio, Juan C., et al.
Publicado: (2023)

An asymmetric approach to preserve common intervals while sorting by reversals
por: Braga, Marília DV, et al.
Publicado: (2009)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
por: Si, Xiaoyan, et al.
Publicado: (2019)

The dark side of immunotherapy
por: Okwundu, Nwanneka, et al.
Publicado: (2021)

First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
por: Wang, Xuechen, et al.
Publicado: (2021)

Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation
por: Ueha, Satoshi, et al.
Publicado: (2017)

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
por: Koh, Kwang Kon, et al.
Publicado: (2017)

Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice
por: Reumerman, M., et al.
Publicado: (2021)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
por: Lagassé, H.A. Daniel, et al.
Publicado: (2021)

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
por: Tang, Fei, et al.
Publicado: (2018)

Perforator plus flaps: Optimizing results while preserving function and esthesis
por: Mehrotra, Sandeep
Publicado: (2010)

Fast randomization of large genomic datasets while preserving alteration counts
por: Gobbi, Andrea, et al.
Publicado: (2014)

Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
por: Sim, Martha M. S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kegusro2gvt2bhcfkqett7ftbf